ROIV
ROIVANT SCIENCES
Health Care·Biotechnology·UNITED STATES
$36.84
MCap $26.6B
as of 2026-08-20
Total
C9w
Fund
E9w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.64
Sentiment 84.4%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$36.84
Adaptive Mean
$37.31
-0.47 vs mean
Adaptive σ
0.37
MIDOS BB
$36.58 – $38.05
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
-0.18
ROE
-8.5%
Z -0.05
Rev Gr
-33.5%
Z -0.96
EPS Gr
—
Z -0.18
OPM Gr
-12278.1%
Z —
FCF Yld
-4.2%
Z -0.15
EPS Surp
0.0%
Z +0.08
EPS 3mo Δ
-63.3%
Z +0.19
Fwd P/E
-21.44
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
7.67
Q6M
6.08
Q12M
14.37
MA 30/100
1.114
Bullish (MA30 > MA100)
α (Jensen)
0.4723
β (12M)
1.10
σ (12M)
0.427
Divergence — Fundamentals vs Momentum
Z Percentile
22%
Q Percentile
100%
Divergence
-77.9
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
27.1
RS Pctl
84%
RS Decile
D9
Persistence
9w
at grade C
Options / OI Analysis
as of 2026-08-21
OI Center
$34.84
-4.6% from spot
Max Pain
$32.00
PCR (OI)
0.10
contrarian_bearish
Skew
-0.28
OI Composite
-1
neutral
Direction
bearish